Λίστα αντικειμένων
The Practice Guidelines Committee of the American Society for Transplantation and Cellular Therapy partnered with
its Transplant Infectious Disease Special Interest Group to update its 2009 compendium-style infectious diseases guidelines for the care of hematopoietic cell transplant (HCT) recipients. A new approach was taken with the goal of better serving clinical providers by publishing each standalone topic in the infectious disease series as a concise format
of frequently asked questions (FAQ), tables, and figures. Adult and pediatric infectious disease and HCT content experts developed and answered FAQs. Topics were finalized with harmonized recommendations that were made by assigning an A through E strength of recommendation paired with a level of supporting evidence graded I through III. The
third topic in the series focuses on the prevention of cytomegalovirus infection and disease in HCT recipients by reviewing prophylaxis and preemptive therapy approaches; key definitions, relevant risk factors, and diagnostic monitoring considerations are also reviewed.
Presenter:Prof.Spyridonidis
Participants:Dr Liga, Dr Tsokanas
its Transplant Infectious Disease Special Interest Group to update its 2009 compendium-style infectious diseases guidelines for the care of hematopoietic cell transplant (HCT) recipients. A new approach was taken with the goal of better serving clinical providers by publishing each standalone topic in the infectious disease series as a concise format
of frequently asked questions (FAQ), tables, and figures. Adult and pediatric infectious disease and HCT content experts developed and answered FAQs. Topics were finalized with harmonized recommendations that were made by assigning an A through E strength of recommendation paired with a level of supporting evidence graded I through III. The
third topic in the series focuses on the prevention of cytomegalovirus infection and disease in HCT recipients by reviewing prophylaxis and preemptive therapy approaches; key definitions, relevant risk factors, and diagnostic monitoring considerations are also reviewed.
Presenter:Prof.Spyridonidis
Participants:Dr Liga, Dr Tsokanas
Σχετικά Αρχεία
Τηλέφωνα Επικοινωνίας:
Γραμματεία MMMO: 2613 603506 (ασθενείς), 2613 604062 (Γραμματεία Διευθυντή) Fax : 2613 604066,email (για ιατρούς): transplant@upatras.gr,
email (για ασθενείς): mmak@upatras.gremail (για θέματα κλινικών μελετών) : gcppatras@gmail.comΜονάδα Μεταμόσχευσης (Νοσηλεία): 2613 603 261Γραφείο Ιατρών: 2613 604064, 2613 604065, Εφημερεύων Ιατρός: 2610 999111 (τηλ. κέντρο ΠΓΝΠ)